Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Dongshi Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and production of active pharmaceutical ingredients (APIs) and high-end pharmaceutical intermediates. The company provides comprehensive Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, focusing on small molecule chemical synthesis and process optimization. Their expertise spans from laboratory-scale R&D to industrial-scale manufacturing, serving both domestic and international markets. Dongshi Pharmaceutical is particularly recognized for its technical capabilities in complex chemical reactions and the development of generic drug technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Dongshi Pharmaceutical Technology.